December 14, 2000 Quest Diagnostics Invests in Structural Bioinformatics, a Leader in Computational Proteomics and Structural Pharmacogenomics December 5, 2000 Moldyn Technology Enhances the Computational Proteomics Repertoire of SBI to Address the Challenges of 21st Century Molecular MedicineTM November 29, 2000 IBM Invests in Structural Bioinformatics, a Leading Life Sciences Company; Deal Will Accelerate Drug Discovery Through Faster Modeling of Proteins November 21, 2000 De Novo Pharmaceuticals Accesses Cutting Edge Protein Targets by Subscription toStructural Bioinformatics' ProMaxTM Database Series and SBdBaseTM November 8, 2000 Structural Bioinformatics, Inc. Announces Discovery of Small-molecule PTP-1B Inhibitors for Treatment of Type-2 Diabetes and Obesity November 7, 2000 Yamanouchi Pharmaceutical Co., Ltd. Accepts SBI-Generated Lead Compound Directed against a Novel Inflammatory Disease Target for In-house Development - Another "Genes to Leads"TM Success November 6, 2000 Structural Bioinformatics Awarded SBIR Grant for Bcl-2 Inhibitors November 3, 2000 Michael J. Savage Joins SBI Management Advisory Board November 1, 2000 Joe Fanelli Joins SBI as Vice President of Sales & Marketing October 16, 2000 Four World-Class Scientists Join SBI's Scientific Advisory Board September 12, 2000 Informax and SBI Announce Distribution Agreement - SBI's High Quality Protein Models to be Offered with InforMax's GenoMaxTM Enterprise System April 4, 2000 Structural Bioinformatics, Inc. Completes $32.6 Million Financing March 27, 2000 Quest Diagnostics and SBI Announce New HIV-1 Integrase Database and Achievement of Milestones in Structural Pharmacogenomic Databases for HIV Drug Development January 17, 2000 Structural Bioinformatics Inc. Acquires Molecular Applications Group's GeneMineTM Technology January 17, 2000 Structural Bioinformatics Inc. Announces Discovery of Small-Molecule Interleukin-5 Receptor Antagonist Leads for Treatment of Eosinophilia-Induced Allergic Diseases January 11, 2000 Structural Bioinformatics Inc. and Quest Diagnostics Announce Launch of Structural Pharmacogenomic Databases for HIV Drug Development January 10, 2000 Structural Bioinformatics' SBdBaseTM 2.0 Provides Improved Functionality for Analyzing Protein Structure to Optimize Drug Candidates